. home.aspx

NEWS

home.aspx
   


Novartis taps Orionis to pursue 'historically elusive targets'

March 06, 2020 / FierceBiotech
SHARESHARESHARE

Novartis has entered into a four-year research collaboration with Orionis Biosciences. The agreement tasks Orionis with applying its technologies to “historically elusive targets” in multiple therapeutic areas. Orionis has been around since 2015 but kept a low profile over most of that time. The transatlantic biotech used its time flying below the radar to establish two platforms, one focused on cytokines and another for “genome-scale drug discovery,” and to use them to generate a pipeline of preclinical assets targeting different phases of the cancer immunity cycle.